Louis WC Chow - Concepedia

Author

Louis WC Chow

University of Hong Kong

Also Known As

L Chow, L W Chow, L W-C Chow, L. Chow, L. W. C. Chow, L. W. Chow, L.W. Chow, L.W.C. Chow, LOUIS CHOW, LOUIS WC CHOW

103

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

University of Hong Kong Unimed Medical Institute Kyoto University Chinese University of Hong Kong Sichuan University

About

Louis WC Chow is an author at University of Hong Kong specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	22	1.4K
2	Health Sciences	4	4	625
3	Nursing	2	2	115
4	Engineering	1	1	34
5	Natural Sciences	1	1	11

Louis WC Chow

Publications

2.7K

Citations

H-Index

Page 1

	Year	Citations
Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial Miguel Martín, Frankie A. Holmes, Bent Ejlertsen, The Lancet Oncology 5-Year AnalysisBreast OncologyOncologyHealth SciencesClinical Trials	2017	578
Breast Cancer in Limited-Resource Countries: An Overview of the Breast Health Global Initiative 2005 Guidelines Benjamin O. Anderson, Roman Shyyan, Alexandru Eniu, The Breast Journal	2006	360
Participation and Satisfaction with Surgical Treatment Decision-Making in Breast Cancer Among Chinese Women Richard Fielding, Miranda Chan, Louis WC Chow, Breast Cancer Research and Treatment NursingQuality Of LifeMedical Decision MakingSurgical OncologyBreast Oncology	2003	90
Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway Xia Li, Xing‐Xing Fan, Zebo Jiang, Pharmacological Research MedicinePathologyBronchial NeoplasmCancer BiologyCancer Treatment	2016	89
Combination neratinib (HKI-272) and paclitaxel therapy in patients with HER2-positive metastatic breast cancer Louis WC Chow, Binghe Xu, Sudeep Gupta, British Journal of Cancer	2013	83
Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer Hilmi Özçelik, Louis WC Chow, Susan J. Done, Oncogene Chinese Sporadic BreastBreast OncologySomatic VariantSomatic MutationsTumor Heterogeneity	1999	78
A phase II, randomized trial using the small molecule tyrosine kinase inhibitor lapatinib as a first-line treatment in patients with FISH positive advanced or metastatic breast cancer Henry Gómez, Miguel A. Chavez, Dinesh Chandra Doval, Journal of Clinical Oncology Metastatic Breast CancerOncologyPhase IiBreast OncologyMedicine	2005	72
The Cell Cycle Checkpoint Gene <i>Rad9</i> Is a Novel Oncogene Activated by 11q13 Amplification and DNA Methylation in Breast Cancer Louis WC Chow, Wings T.Y. Loo, Tai Kwong Chan, Cancer Research	2005	70
Association of matrix metalloproteinase (MMP)-1, 3, 9, interleukin (IL)-2, 8 and cyclooxygenase (COX)-2 gene polymorphisms with chronic periodontitis in a Chinese population Guangyue Li, Yuan Yue, Ye Tian, Cytokine InflammationGenetic EpidemiologyImmunologyInflammatory MarkerChronic Periodontitis	2012	66
<i>Rhodiola algida</i>improves chemotherapy-induced oral mucositis in breast cancer patients Wings TY Loo, LJ Jin, Louis WC Chow, Expert Opinion on Investigational Drugs	2010	60

Page 1